Skip to main content
Equibles

SUPRIYA · Supriya Lifescience Limited · Financials

Use SUPRIYA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SUPRIYA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
632.10 INR -9.95 (-1.55%) At close · Nov 13
Rebalance outlook locked
Market Cap
50.87B INR
Shares
80.48M
Volume · Nov 13 253.34K Avg daily vol (3M) 368.16K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
8.28B +18.9%
FY2026 Revenue FY2022–FY2026
Net Income
2.09B +11.3%
FY2026 Net Income FY2022–FY2026
Operating Cash Flow
1.86B +12.8%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022
INR 8.79B 8.28B 6.96B 5.7B 4.61B 5.3B
INR 337.18M 284.09M 204.44M 158.11M 118.15M 101.18M
INR 17.93M 18.89M 16.86M 21.1M 30.84M 41.98M
INR 2.38B 2.75B 2.48B 1.66B 1.23B 2.07B
INR 604.22M 656.59M 605.23M 465.76M 336.3M 554.35M
INR 1.77B 2.09B 1.88B 1.19B 898.59M 1.52B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 285.36M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.